keyword
MENU ▼
Read by QxMD icon Read
search

Predictors switching

keyword
https://www.readbyqxmd.com/read/27883369/acinetobacter-prosthetic-joint-infection-treated-with-debridement-and-high-dose-tigecycline
#1
Andrea Vila, Hugo Pagella, Claudio Amadio, Alejandro Leiva
Prosthesis retention is not recommended for multidrug-resistant Acinetobacter prosthetic joint infection due to its high failure rate. Nevertheless, replacing the prosthesis implies high morbidity and prolonged hospitalization. Although tigecycline is not approved for the treatment of prosthetic joint infection due to multidrug resistant Acinetobacter baumannii, its appropriate use may preclude prosthesis exchange. Since the area under the curve divided by the minimum inhibitory concentration is the best pharmacodynamic predictor of its efficacy, we used tigecycline at high dose, in order to optimize its efficacy and achieve implant retention in 3 patients who refused prosthesis exchange...
November 8, 2016: Infection & Chemotherapy
https://www.readbyqxmd.com/read/27864889/goal-directed-treatment-for-osteoporosis-a-progress-report-from-the-asbmr-nof-working-group-on-goal-directed-treatment-for-osteoporosis
#2
REVIEW
Steven R Cummings, Felicia Cosman, Michael E Lewiecki, John T Schousboe, Douglas Bauer, Dennis Black, Thomas Brown, Angela M Cheung, Kathleen Cody, Cyrus Cooper, Adolfo Diez-Perez, Richard Eastell, Peyman Hadji, Takayuki Hosoi, Suzanne Jan De Beur, Risa Kagan, Douglas P Kiel, Ian Reid, Daniel H Solomon, Susan Randall
The American Society for Bone and Mineral Research and the United States National Osteoporosis Foundation (NOF) formed a working group to develop principles of goal-directed treatment and identify gaps that need to be filled to implement this approach. With goal-directed treatment, a treatment goal would first be established choice of treatment determined by the probability of achieving that goal. Goals of treatment would be freedom from fracture, a T-score > -2.5, which is above the NOF threshold for initiating treatment, or achievement of an estimated risk level below the threshold for initiating treatment...
November 19, 2016: Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research
https://www.readbyqxmd.com/read/27860025/low-level-alcohol-consumption-during-adolescence-and-its-impact-on-cognitive-control-development
#3
Sarah Jurk, Eva Mennigen, Thomas Goschke, Michael N Smolka
Adolescence is a critical period for maturation of cognitive control and most adolescents start experimenting with alcohol around that time. On the one hand, recent studies indicate that low control abilities predict future problematic alcohol use. On the other hand, binge drinking during young adulthood can (further) impair cognitive control. However, so far no study examined the effects of low-level alcohol use during adolescence. In the present longitudinal fMRI study, we therefore investigated the development of cognitive control in a community-based sample of 92 adolescents at ages 14, 16 and 18...
November 17, 2016: Addiction Biology
https://www.readbyqxmd.com/read/27834042/effect-of-oral-anticoagulant-therapy-on-mortality-in-end-stage-renal-disease-patients-with-atrial-fibrillation-a-prospective-study
#4
Simonetta Genovesi, Paola Rebora, Maurizio Gallieni, Andrea Stella, Fabio Badiali, Ferruccio Conte, Sonia Pasquali, Silvio Bertoli, Patrizia Ondei, Giuseppe Bonforte, Claudio Pozzi, Emanuela Rossi, Maria Grazia Valsecchi, Antonio Santoro
BACKGROUND: The aim of this study was to evaluate, in a cohort of haemodialysis patients with atrial fibrillation (AF), the relationship between oral anticoagulant therapy (OAT) and mortality, thromboembolic events and haemorrhage. METHODS: Two hundred and ninety patients with AF were prospectively followed for 4 years. Warfarin and antiplatelet intake, age, dialytic age, comorbidities, CHA2DS2-VASc and HAS-BLED scores were considered as predictors of risk of death, thromboembolism and bleeding events...
November 11, 2016: Journal of Nephrology
https://www.readbyqxmd.com/read/27828840/high-satisfaction-with-direct-switching-from-antimuscarinics-to-mirabegron-in-patients-receiving-stable-antimuscarinic-treatment
#5
Chun-Hou Liao, Hann-Chorng Kuo
Mirabegron, which was the first β3-adrenoceptor agonist introduced for use in clinical practice, has been extensively evaluated in overactive bladder (OAB) patients in several phase II and III studies. However, most of the enrolled patients were treatment naive or had experienced a wash-out period before the introduction of mirabegron. No study has reported the treatment results of a direct switch from antimuscarinics to mirabegron, which may more commonly occur in clinical practice. This is an observational study to assess the therapeutic efficacy and safety of directly switching from antimuscarinics to mirabegron in patients with OAB receiving stable antimuscarinic treatment...
November 2016: Medicine (Baltimore)
https://www.readbyqxmd.com/read/27825309/tuberculosis-treatment-outcomes-of-six-and-eight-month-treatment-regimens-in-districts-of-southwestern-ethiopia-a-comparative-cross-sectional-study
#6
Abyot Asres, Degu Jerene, Wakgari Deressa
BACKGROUND: A switch of continuation phase tuberculosis (TB) treatment regimen from Ethambutol (E) and Isoniazid (H) combination for 6 months (6EH) to Rifampicin (R) and Isoniazid (H) combination for 4 months (4RH) was recommended. However, the effect of the regimen switch in Ethiopian setting is not known. METHODS: A comparative cross-sectional study among 790 randomly selected new cases of TB (395 each treated with 4RH and 6EH during the continuation phase) was conducted in nine health centers and one hospital in three zones in southwestern Ethiopia...
November 8, 2016: BMC Infectious Diseases
https://www.readbyqxmd.com/read/27822021/time-to-lack-of-persistence-with-pharmacological-treatment-among-patients-with-current-depressive-episodes-a-natural-study-with-1-year-follow-up
#7
Kanglai Li, Qinling Wei, Guanying Li, Xiangjun He, Yingtao Liao, Zhaoyu Gan
INTRODUCTION: Medication nonadherence remains a big challenge for depressive patients. This study aims to assess and compare the medication persistence between unipolar depression (UD) and bipolar depression (BD). METHODS: A total of 146 UD and 187 BD patients were recruited at their first index prescription. Time to lack of persistence with pharmacological treatment (defined as a gap of at least 60 days without taking any medication) was calculated, and clinical characteristics were collected...
2016: Patient Preference and Adherence
https://www.readbyqxmd.com/read/27800524/slow-cd4-t-cell-recovery-in-human-immunodeficiency-virus-hepatitis-b-virus-coinfected-patients-initiating-truvada-based-combination-antiretroviral-therapy-in-botswana
#8
Motswedi Anderson, Simani Gaseitsiwe, Sikhulile Moyo, Kerapetse P Thami, Terence Mohammed, Ditiro Setlhare, Theresa K Sebunya, Eleanor A Powell, Joseph Makhema, Jason T Blackard, Richard Marlink, Max Essex, Rosemary M Musonda
Background.  Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection has emerged as an important cause of morbidity and mortality. We determined the response to Truvada-based first-line combination antiretroviral therapy (cART) in HIV/HBV-coinfected verus HIV-monoinfected patients in Botswana. Methods.  Hepatitis B virus surface antigen (HBsAg), HBV e antigen (HBeAg), and HBV deoxyribonucleic acid (DNA) load were determined from baseline and follow-up visits in a longitudinal cART cohort of Truvada-based regimen...
September 2016: Open Forum Infectious Diseases
https://www.readbyqxmd.com/read/27797443/treatment-outcomes-of-over-1000-patients-on-second-line-protease-inhibitor-based-antiretroviral-therapy-from-four-public-sector-hiv-treatment-facilities-across-johannesburg-south-africa
#9
Kate Shearer, Denise Evans, Faith Moyo, Julia K Rohr, Rebecca Berhanu, Liudmyla Van Den Berg, Lawrence Long, Ian Sanne, Matthew P Fox
OBJECTIVES: To report predictors of outcomes of second-line ART for HIV treatment in resource-limited settings. METHODS: All adult ART-naïve patients who initiated standard first-line treatment between April 2004-February 2012 at four public-sector health facilities in Johannesburg, South Africa, experienced virologic failure, and initiated standard second-line therapy were included. We assessed predictors of attrition (death and loss to follow-up [≥3 months late for a scheduled visit]) using Cox proportional hazards regression and predictors of virologic suppression (viral load <400 copies/ml ≥3 months after switch) using modified Poisson regression with robust error estimation at one year and ever after second-line ART initiation...
October 31, 2016: Tropical Medicine & International Health: TM & IH
https://www.readbyqxmd.com/read/27784021/characteristics-and-predictors-of-early-and-delayed-responders-to-ranibizumab-treatment-in-neovascular-age-related-macular-degeneration-a-retrospective-analysis-from-the-anchor-marina-harbor-and-catt-trials
#10
Richard Gale, Jean-Francois Korobelnik, Yit Yang, Tien Y Wong
PURPOSE: This retrospective review examined visual acuity (VA) in subjects with neovascular age-related macular degeneration and identified early and delayed response to ranibizumab. PROCEDURES: MARINA, ANCHOR, HARBOR, and CATT published data were examined for response with monthly versus individualized dosing and predictors of early versus delayed response. RESULTS: Data were available for 1,631 subjects; 18-29% were early gainers and 15-16% were delayed gainers...
October 27, 2016: Ophthalmologica. Journal International D'ophtalmologie
https://www.readbyqxmd.com/read/27779086/genetic-predictors-of-drug-hypersensitivity
#11
José A Cornejo-García, Abderrahim Oussalah, Miguel Blanca, Rosa-María Guéant-Rodríguez, Cristobalina Mayorga, Julie Waton, Annick Barbaud, Francesco Gaeta, Antonino Romano, Jean-Louis Guéant
Our knowledge of genetic predisposing factors of drug hypersensitivity reactions (DHRs) is still scarce. The analysis of the genetic basis of these reactions may contribute to dissect the underlying mechanisms. We will outline current knowledge of the genetic predictors of most common DHRs, including reactions to betalactam antibiotics (BLs), nonsteroidal anti-inflammatory drugs (NSAIDs) and biological agents. The predictors of DHRs to BLs are mostly linked to IgE-class switching, IgE pathway and atopy (IL4R, NOD2, LGALS3) in replicated candidate gene studies, and to antigen presentation (HLA-DRA) in the single replicated GWAS performed so far...
September 27, 2016: Current Pharmaceutical Design
https://www.readbyqxmd.com/read/27764122/blood-plasma-derived-anti-glycan-antibodies-to-sialylated-and-sulfated-glycans-identify-ovarian-cancer-patients
#12
Tatiana Pochechueva, Alexander Chinarev, Andreas Schoetzau, André Fedier, Nicolai V Bovin, Neville F Hacker, Francis Jacob, Viola Heinzelmann-Schwarz
Altered levels of naturally occurring anti-glycan antibodies (AGA) circulating in human blood plasma are found in different pathologies including cancer. Here the levels of AGA directed against 22 negatively charged (sialylated and sulfated) glycans were assessed in high-grade serous ovarian cancer (HGSOC, n = 22) patients and benign controls (n = 31) using our previously developed suspension glycan array (SGA). Specifically, the ability of AGA to differentiate between controls and HGSOC, the most common and aggressive type of ovarian cancer with a poor outcome was determined...
2016: PloS One
https://www.readbyqxmd.com/read/27754069/os-18-01-correlation-between-cognitive-decline-and-blood-pressure-in-elderly-patients-with-controlled-hypertension
#13
Adrian Noriega De La Colina, Rong Wu, Laurence Desjardins-Crépeau, Pierre Larochelle, Maxime Lamarre-Cliche, Louis Bherer, Hélène Girouard
OBJECTIVE: The objective of this study was to assess cognitive performance in older adults treated and controlled for blood pressure (BP) when compared to untreated normotensive subjects, and to determine whether blood pressure still correlates with poorer cognitive performances. DESIGN AND METHOD: Forty-eight older adults aged between 65 and 85 years were recruited in the community and divided into two groups: normotensive (n = 26) and controlled hypertensive (n = 22)...
September 2016: Journal of Hypertension
https://www.readbyqxmd.com/read/27733983/early-childhood-language-outcomes-after-arterial-switch-operation-a-prospective-cohort-study
#14
Matt S Hicks, Reginald S Sauve, Charlene M T Robertson, Ari R Joffe, Gwen Alton, Dianne Creighton, David B Ross, Ivan M Rebeyka
BACKGROUND: Developmental and language outcomes at 2 years of age of children who had arterial switch operation (ASO) for transposition of the great arteries 2004-2010 are described. METHODS: In this prospective cohort study, 91/98 (93 %) children who underwent ASO were assessed at 2 years of age with the Bayley Scales of Infant & Toddler Development-3rd Edition. Outcomes were compared by patient and perioperative variables using bivariate and multivariate regression analyses to identify predictors of language delay...
2016: SpringerPlus
https://www.readbyqxmd.com/read/27730309/real-world-effectiveness-of-anti-tnf-switching-in-psoriatic-arthritis-a-systematic-review-of-the-literature
#15
Soumya M Reddy, Sheila Crean, Amber L Martin, Meghan D Burns, Jacqueline B Palmer
Anti-tumor necrosis factors (Anti-TNFs) are a class of biologic disease-modifying anti-rheumatic drugs indicated for the treatment of moderate-to-severe psoriatic arthritis (PsA). Refractory patients are commonly managed by switching from one anti-TNF to another. To assess the evidence on the effectiveness of anti-TNF cycling in PsA patients, a systematic review of the literature was conducted. MEDLINE- and Embase-indexed English-language publications were systematically searched from 1995 to 2015 for studies assessing real-world effectiveness outcomes of anti-TNF cycling in PsA patients...
October 12, 2016: Clinical Rheumatology
https://www.readbyqxmd.com/read/27729063/development-and-evaluation-of-a-markov-model-to-predict-changes-in-schistosomiasis-prevalence-in-response-to-praziquantel-treatment-a-case-study-of-schistosoma-mansoni-in-uganda-and-mali
#16
Arminder Deol, Joanne P Webster, Martin Walker, Maria-Gloria Basáñez, T Déirdre Hollingsworth, Fiona M Fleming, Antonio Montresor, Michael D French
BACKGROUND: Understanding whether schistosomiasis control programmes are on course to control morbidity and potentially switch towards elimination interventions would benefit from user-friendly quantitative tools that facilitate analysis of progress and highlight areas not responding to treatment. This study aimed to develop and evaluate such a tool using large datasets collected during Schistosomiasis Control Initiative-supported control programmes. METHODS: A discrete-time Markov model was developed using transition probability matrices parameterized with control programme longitudinal data on Schistosoma mansoni obtained from Uganda and Mali...
October 12, 2016: Parasites & Vectors
https://www.readbyqxmd.com/read/27707820/understanding-vasopressor-intervention-and-weaning-risk-prediction-in-a-public-heterogeneous-clinical-time-series-database
#17
Mike Wu, Marzyeh Ghassemi, Mengling Feng, Leo A Celi, Peter Szolovits, Finale Doshi-Velez
BACKGROUND: The widespread adoption of electronic health records allows us to ask evidence-based questions about the need for and benefits of specific clinical interventions in critical-care settings across large populations. OBJECTIVE: We investigated the prediction of vasopressor administration and weaning in the intensive care unit. Vasopressors are commonly used to control hypotension, and changes in timing and dosage can have a large impact on patient outcomes...
October 5, 2016: Journal of the American Medical Informatics Association: JAMIA
https://www.readbyqxmd.com/read/27692898/peri-implant-bone-loss-around-platform-switched-morse-taper-connection-implants-a-prospective-60-month-follow-up-study
#18
M Cassetta, A Driver, G Brandetti, S Calasso
The aim of this study was to measure the crestal bone level changes at 60 months of follow-up and to evaluate the influence of biologically relevant, anatomical, and implant-related variables. A prospective study design was used. STROBE guidelines were followed. A total of 576 implants were inserted in 270 patients needing an implant-supported, partial, fixed dental prosthesis or a single crown. Standardized peri-apical radiographs were obtained at 2 months (time of implant-abutment connection and prosthetic loading) and 60 months of follow-up...
September 28, 2016: International Journal of Oral and Maxillofacial Surgery
https://www.readbyqxmd.com/read/27690752/multicomponent-analysis-of-a-digital-trail-making-test
#19
Robert P Fellows, Jessamyn Dahmen, Diane Cook, Maureen Schmitter-Edgecombe
OBJECTIVE: The purpose of the current study was to use a newly developed digital tablet-based variant of the TMT to isolate component cognitive processes underlying TMT performance. METHOD: Similar to the paper-based trail making test, this digital variant consists of two conditions, Part A and Part B. However, this digital version automatically collects additional data to create component subtest scores to isolate cognitive abilities. Specifically, in addition to the total time to completion and number of errors, the digital Trail Making Test (dTMT) records several unique components including the number of pauses, pause duration, lifts, lift duration, time inside each circle, and time between circles...
October 3, 2016: Clinical Neuropsychologist
https://www.readbyqxmd.com/read/27671328/clinical-implications-of-switching-lipid-lowering-treatment-from-rosuvastatin-to-other-agents-in-primary-care
#20
Furio Colivicchi, Michele Massimo Gulizia, Laura Franzini, Giuseppe Imperoli, Lorenzo Castello, Alessandro Aiello, Claudio Ripellino, Nazarena Cataldo
INTRODUCTION: Switching from any statin to another non-equipotent lipid lowering treatment (LLT) may cause a low-density lipoprotein cholesterol increase and has been associated with a higher probability of negative cardiovascular outcomes. The aim of the study was to assess the impact of switching from rosuvastatin to any other LLT on clinical outcomes in primary care. METHODS: This was a retrospective analysis based on data from IMS Health Longitudinal Patient Database, which is a general practice database including information of more than 1...
November 2016: Advances in Therapy
keyword
keyword
118155
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"